New gout Drug's absorption under the microscope: food may change the game
NCT ID NCT07346027
First seen Jun 25, 2026 · Last updated Jul 31, 2026 · Updated 3 times
Summary
This early-stage trial is testing a new drug called F-02-2-Na, designed to lower uric acid levels in people with gout or high uric acid. The study will give 12 healthy adults a single dose of the drug, once on an empty stomach and once after a meal, to see if food changes how the drug is absorbed. The main goal is to check safety and measure drug levels in the blood, not to treat any condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- F-02-2-Na (a drug for lowering uric acid)
- What this could lead to
- If successful, this study will help determine whether F-02-2-Na should be taken with or without food, guiding future dosing for gout and high uric acid.
- What could go wrong
- This is a very early Phase 1 trial with only 12 healthy volunteers. It does not test effectiveness in patients, and results may not predict real-world outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERURICEMIA WITH OR WITHOUT GOUT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510120, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.